Form D · Biotechnology
Nutra Biopharma Corp.
Redlands, CA · CIK 0001461583
Offering snapshot reported Jan 20, 2010 · SEC filing
- Reported sold
- $20K Offering amount: $20K
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 18, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 20, 2010 | Initial | $20,000 | No comparison | 30 | SEC filing |
| Apr 8, 2009 | Initial | $3,350 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 04.1, 04.2, 04.3
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-130032
Source: Form D, filed Jan 20, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Boyd | Director, Executive |
| Zirk Engelbrecht | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
646 West Highland Avenue
Redlands, CA, 92373
Redlands, CA, 92373